4cell TherapiesS.A.Active

Research and experimental development on biotechnology

KRS: 0000692806 NIP: 5252547574 REGON: 14653588300000

Overview

Registry date
2017-09-01
Share capital
$680,933.44
Activity description

4cell Therapies is a company that develops CAR-T therapies for treating solid tumors, including challenging cases like pancreatic cancer, and hematological cancers such as leukemia and lymphoma. The company conducts research and development in Poland, utilizing advanced genetic engineering to create antigen receptors that target and destroy cancer cells. They also optimize production processes to meet GMP standards, ensuring scalability for future commercialization.

Registered address
Ul. Bojkowska 59 C, 44-100 Gliwice, Poland
Website
4celltherapies.comWebsite active
Electronic delivery address
AE:PL-61449-60062-HDUSJ-16

Industry

NameCode
Research and experimental development on biotechnology
72.11.Z
Other publishing activities
58.19.Z
Other information service activities not elsewhere classified
63.99.Z
Public relations and communication activities
70.21.Z
Business and other management consultancy activities
70.22.Z

Bank accounts

Registered as a VAT taxpayer on 2013-02-07.Active

Authorized Representatives

Ownership

Competitors

NameRevenueWebsite
Pure BiologicsS.A.$149,394.35purebiologics.com
FcbiotechS.A.$148,945.77fcbiotech.pl
UveraS.A.$155,384.29uvera.eu
IntelliseqS.A.$111,419.60intelliseq.pl
WPD PharmaceuticalsS.A.$87,561.70wpdpharmaceuticals.pl/contact/wpdsa/
GenomtecS.A.$73,665.75genomtec.com
InventroS.A.$12,176.61inventro.co
ArthecS.A.$10,911.16arthec.eu
Oncotherics PolandS.A.$7,565.33oncotherics.com
Ncage TherapeuticsS.A.$29.14ncage.org

Change history

EventDetailsDate
Share capital change2446741.50 PLN → 2520815.60 PLN2026-05-15

FAQ

Last updated: 2026-07-15